The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
CAR-T Meeting 2024 | The importance of a multidisciplinary team when treating autoimmune disease with CAR T-cell therapy
Raffaella Greco, MD, PhD, San Raffaele Hospital, Milan, Italy, discusses the development of the CAR T-cell therapeutic approach for the treatment of autoimmune disease, emphasizing the need for a multidisciplinary team throughout the entirety of the treatment process in these patients. This interview took place at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
